Clinical trial
A Pilot Study of LTB4 in HIV-1 Infected Adults
NCT00251537 · LTB4 Sweden AB, Industry · Completed
Key facts
| NCT number | NCT00251537 |
|---|---|
| Title | A Pilot Study of LTB4 in HIV-1 Infected Adults |
| Official title | A Pilot Study Assessing Safety and Antiretroviral Activity of Intravenously Administered LTB4 in HIV-1 Infected Adults With a CD4 Count Greater Than 250 Cells/mm3 and a Viral Load Greater Than 5,000 Copies/mL, and Who Have Not Received Antiretroviral Therapy Within Two Months |
| Lead sponsor | LTB4 Sweden AB, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | LTB4 |
| Enrollment | 40 |
| Start date | Nov 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Nov 10, 2005 |
| Last update posted | Jul 10, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: